Ticlid 250
Generic Name: ticlopidine
Pill imprint Ticlid 250 has been identified as Ticlid 250 mg.
Ticlid is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Ticlid 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Ticlid Images
- Generic Name:
- ticlopidine
- Imprint:
-
Ticlid
250 - Strength:
- 250 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- citric acid
magnesium stearate
microcrystalline cellulose
povidone
starch
stearic acid
polyethylene glycol
titanium dioxide
FD&C Blue No. 1 Aluminium Lake
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-0018
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3783 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.


